ADP-ribosyl cyclase and ryanodine receptors mediate endothelin ETA and ETB receptor-induced renal vasoconstriction in vivo
about
Antenatal betamethasone increases vascular reactivity to endothelin-1 by upregulation of CD38/cADPR signaling.CD38 mediates angiotensin II-induced intracellular Ca(2+) release in rat pulmonary arterial smooth muscle cells.Regulation of blood pressure and salt homeostasis by endothelin.RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatment.Antenatal betamethasone has a sex-dependent effect on the in vivo response to endothelin in adult sheep.Regulation of renin release via cyclic ADP-ribose-mediated signaling: evidence from mice lacking CD38 gene.Mice lacking the ADP ribosyl cyclase CD38 exhibit attenuated renal vasoconstriction to angiotensin II, endothelin-1, and norepinephrine.NAADP receptors mediate calcium signaling stimulated by endothelin-1 and norepinephrine in renal afferent arterioles.Nicotinamide benefits both mothers and pups in two contrasting mouse models of preeclampsia.Endothelin and the renal microcirculation.Physiology of endothelin and the kidney.Cyclic ADP-Ribose and NAADP in Vascular Regulation and Diseases.Glaucoma as a Metabolic Optic Neuropathy: Making the Case for Nicotinamide Treatment in Glaucoma.Renal vasoconstriction by vasopressin V1a receptors is modulated by nitric oxide, prostanoids, and superoxide but not the ADP ribosyl cyclase CD38.Endothelin type A and B receptors in the control of afferent and efferent arterioles in mice.Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism.
P2860
Q34159706-A3D9AAF0-E85D-4676-B65E-74C622F2725DQ35207727-0EAD1551-F7F0-4320-96B9-36B3039F1324Q35609851-D1B86834-FC5A-409D-9580-DF6974903C9FQ36213489-C2C6AF49-EA96-4446-A574-00824CAAD915Q36770756-B866CF66-BBD5-4592-975F-3B17F1A338F6Q37121300-590FA5D3-38BE-47CD-96AD-BDB105FCFDBEQ37264323-F663140E-3003-4F42-97CD-A9403BC6CCFFQ37298467-DE024DA6-0E4F-4FD9-B888-690202C1D947Q37451322-BDE6AEC2-05EF-44FB-A8DA-F0A9269E5100Q37573188-4CE1CD10-9CFF-4735-AAA0-2F59B22EB2E1Q37613679-C4D9A393-3D0F-4C99-AAAF-FDAC4EE337B9Q37704928-1C0E0F61-6C8C-4848-BD9E-8424D1D189E2Q38600194-CD4BF12D-CEE3-4767-92D8-2AEFA819892DQ39706739-95E92F7E-CA15-41F6-B9EC-6E3F902B7173Q42476535-D1BF436B-8D2F-49DB-877D-8062F869F842Q46023332-2C174288-BE05-4612-8375-384FC0D5FE8D
P2860
ADP-ribosyl cyclase and ryanodine receptors mediate endothelin ETA and ETB receptor-induced renal vasoconstriction in vivo
description
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im August 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/08/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/08/01)
@nl
наукова стаття, опублікована в серпні 2008
@uk
مقالة علمية (نشرت في أغسطس 2008)
@ar
name
ADP-ribosyl cyclase and ryanod ...... renal vasoconstriction in vivo
@ast
ADP-ribosyl cyclase and ryanod ...... renal vasoconstriction in vivo
@en
ADP-ribosyl cyclase and ryanod ...... renal vasoconstriction in vivo
@nl
type
label
ADP-ribosyl cyclase and ryanod ...... renal vasoconstriction in vivo
@ast
ADP-ribosyl cyclase and ryanod ...... renal vasoconstriction in vivo
@en
ADP-ribosyl cyclase and ryanod ...... renal vasoconstriction in vivo
@nl
prefLabel
ADP-ribosyl cyclase and ryanod ...... renal vasoconstriction in vivo
@ast
ADP-ribosyl cyclase and ryanod ...... renal vasoconstriction in vivo
@en
ADP-ribosyl cyclase and ryanod ...... renal vasoconstriction in vivo
@nl
P2860
P1476
ADP-ribosyl cyclase and ryanod ...... renal vasoconstriction in vivo
@en
P2093
Tiffany L. Thai
William J. Arendshorst
P2860
P304
P356
10.1152/AJPRENAL.00512.2007
P577
2008-08-01T00:00:00Z